Understanding the mechanisms of FasL-induced photoreceptor cell death and endogenous neuroprotection will provide new therapeutic targets for preventing loss of photoreceptors in retinal diseases affected by separation of photoreceptors from RPE, such as rhegmatogenous retinal detachment. This evidence concerns the gene FASLG and Abnormal retinal morphology.